The fact that L1CAM expression in our study was prognostic in the intermediate-risk group of p53 wt/NSMP tumours using both preoperative and postoperative variables indicates that the addition of L1CAM IHC to the ProMisE (or similar) molecular classifier could add useful information for both prognosis and treatment (Table 4). Here, L1CAM is linked to neoplasm.